Furthermore, it is hoped that recent developments in the identification of biomarkers like miRNAs in exosomes and understanding of circadian clock genes and their dysregulation at different stages will prove to be potential future generation biomarkers, which can revolutionize AD diagnostics. Here, CLOCK is linked to Alzheimer disease.